Natera partners with Diakonos to track fast-tracked melanoma immunotherapy
Share
Natera (NASDAQ:TRA) has entered into a clinical collaboration with Diakonos Oncology to deploy its liquid biopsy technology to track patient responses during an active trial for an aggressive skin cancer therapy.